337 related articles for article (PubMed ID: 34987646)
1. Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes.
Uranga-Murillo I; Morte E; Hidalgo S; Pesini C; García-Mulero S; Sierra JL; Santiago L; Arias M; De Miguel D; Encabo-Berzosa MDM; Gracia-Tello B; Sanz-Pamplona R; Martinez-Lostao L; Galvez EM; Paño-Pardo JR; Ramirez-Labrada A; Pardo J
Theranostics; 2022; 12(1):290-306. PubMed ID: 34987646
[TBL] [Abstract][Full Text] [Related]
2. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
3. NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19.
Bergantini L; d'Alessandro M; Cameli P; Cavallaro D; Gangi S; Cekorja B; Sestini P; Bargagli E
Cells; 2021 Nov; 10(11):. PubMed ID: 34831404
[TBL] [Abstract][Full Text] [Related]
4. Unique immunological profile in patients with COVID-19.
Varchetta S; Mele D; Oliviero B; Mantovani S; Ludovisi S; Cerino A; Bruno R; Castelli A; Mosconi M; Vecchia M; Roda S; Sachs M; Klersy C; Mondelli MU
Cell Mol Immunol; 2021 Mar; 18(3):604-612. PubMed ID: 33060840
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
[TBL] [Abstract][Full Text] [Related]
6. Elevated Exhaustion Levels of NK and CD8
Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
Front Immunol; 2020; 11():580237. PubMed ID: 33154753
[TBL] [Abstract][Full Text] [Related]
7. Immunological changes in different patient populations with chronic hepatitis C virus infection.
Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
[TBL] [Abstract][Full Text] [Related]
8. Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome.
Schrijver B; Assmann JLJC; van Gammeren AJ; Vermeulen RCH; Portengen L; Heukels P; Langerak AW; Dik WA; van der Velden VHJ; Ermens TAAM
Eur Cytokine Netw; 2020 Dec; 31(4):154-167. PubMed ID: 33648924
[TBL] [Abstract][Full Text] [Related]
9. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
Tincati C; Cannizzo ES; Giacomelli M; Badolato R; d'Arminio Monforte A; Marchetti G
Front Immunol; 2020; 11():580987. PubMed ID: 33193384
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
[TBL] [Abstract][Full Text] [Related]
11. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
[TBL] [Abstract][Full Text] [Related]
12. T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19.
Zenarruzabeitia O; Astarloa-Pando G; Terrén I; Orrantia A; Pérez-Garay R; Seijas-Betolaza I; Nieto-Arana J; Imaz-Ayo N; Pérez-Fernández S; Arana-Arri E; Borrego F
Front Immunol; 2021; 12():655934. PubMed ID: 33777054
[TBL] [Abstract][Full Text] [Related]
13. Persistent High Percentage of HLA-DR
Du J; Wei L; Li G; Hua M; Sun Y; Wang D; Han K; Yan Y; Song C; Song R; Zhang H; Han J; Liu J; Kong Y
Front Immunol; 2021; 12():735125. PubMed ID: 34567001
[TBL] [Abstract][Full Text] [Related]
14. Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity.
Kulkarni-Munje A; Palkar S; Shrivastava S; Lalwani S; Mishra AC; Arankalle VA
Immun Inflamm Dis; 2021 Jun; 9(2):419-434. PubMed ID: 33452858
[TBL] [Abstract][Full Text] [Related]
15. An immune-based biomarker signature is associated with mortality in COVID-19 patients.
Abers MS; Delmonte OM; Ricotta EE; Fintzi J; Fink DL; de Jesus AAA; Zarember KA; Alehashemi S; Oikonomou V; Desai JV; Canna SW; Shakoory B; Dobbs K; Imberti L; Sottini A; Quiros-Roldan E; Castelli F; Rossi C; Brugnoni D; Biondi A; Bettini LR; D'Angio' M; Bonfanti P; Castagnoli R; Montagna D; Licari A; Marseglia GL; Gliniewicz EF; Shaw E; Kahle DE; Rastegar AT; Stack M; Myint-Hpu K; Levinson SL; DiNubile MJ; Chertow DW; Burbelo PD; Cohen JI; Calvo KR; Tsang JS; ; Su HC; Gallin JI; Kuhns DB; Goldbach-Mansky R; Lionakis MS; Notarangelo LD
JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33232303
[TBL] [Abstract][Full Text] [Related]
16. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
Rébillard RM; Charabati M; Grasmuck C; Filali-Mouhim A; Tastet O; Brassard N; Daigneault A; Bourbonnière L; Anand SP; Balthazard R; Beaudoin-Bussières G; Gasser R; Benlarbi M; Moratalla AC; Solorio YC; Boutin M; Farzam-Kia N; Descôteaux-Dinelle J; Fournier AP; Gowing E; Laumaea A; Jamann H; Lahav B; Goyette G; Lemaître F; Mamane VH; Prévost J; Richard J; Thai K; Cailhier JF; Chomont N; Finzi A; Chassé M; Durand M; Arbour N; Kaufmann DE; Prat A; Larochelle C
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33635833
[TBL] [Abstract][Full Text] [Related]
17. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
Front Immunol; 2021; 12():668725. PubMed ID: 34276659
[TBL] [Abstract][Full Text] [Related]
18. Single-cell analysis reveals cell communication triggered by macrophages associated with the reduction and exhaustion of CD8
He L; Zhang Q; Zhang Y; Fan Y; Yuan F; Li S
Cell Commun Signal; 2021 Jul; 19(1):73. PubMed ID: 34238338
[TBL] [Abstract][Full Text] [Related]
19. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
[TBL] [Abstract][Full Text] [Related]
20. Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.
Han M; Ma K; Wang X; Yan W; Wang H; You J; Wang Q; Chen H; Guo W; Chen T; Ning Q; Luo X
Front Endocrinol (Lausanne); 2021; 12():596518. PubMed ID: 33776910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]